AU7352096A - Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers - Google Patents

Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers

Info

Publication number
AU7352096A
AU7352096A AU73520/96A AU7352096A AU7352096A AU 7352096 A AU7352096 A AU 7352096A AU 73520/96 A AU73520/96 A AU 73520/96A AU 7352096 A AU7352096 A AU 7352096A AU 7352096 A AU7352096 A AU 7352096A
Authority
AU
Australia
Prior art keywords
thioethers
peptides
antioxidant
proteins
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73520/96A
Inventor
Jonas Fransson
Ronny Lundin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Publication of AU7352096A publication Critical patent/AU7352096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU73520/96A 1995-10-20 1996-10-14 Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers Abandoned AU7352096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9503679 1995-10-20
SE9503679A SE9503679D0 (en) 1995-10-20 1995-10-20 antioxidants
PCT/SE1996/001302 WO1997014430A1 (en) 1995-10-20 1996-10-14 Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers

Publications (1)

Publication Number Publication Date
AU7352096A true AU7352096A (en) 1997-05-07

Family

ID=20399893

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73520/96A Abandoned AU7352096A (en) 1995-10-20 1996-10-14 Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers

Country Status (3)

Country Link
AU (1) AU7352096A (en)
SE (1) SE9503679D0 (en)
WO (1) WO1997014430A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902718B2 (en) 2000-10-24 2005-06-07 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
US6881396B2 (en) 2000-10-24 2005-04-19 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
US6989138B2 (en) 2000-10-24 2006-01-24 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
GB2368339B (en) 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
DE60232017D1 (en) 2001-12-21 2009-05-28 Novo Nordisk Healthcare Ag LIQUID COMPOSITION OF FACTOR VII POLYPEPTIDES
JP4648002B2 (en) 2002-06-21 2011-03-09 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Stabilized solid composition of factor VII polypeptide
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
EP1628677B1 (en) 2003-05-23 2010-01-13 Novo Nordisk Health Care AG Protein stabilization in solution
AU2004264282B2 (en) 2003-08-14 2010-10-14 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of Factor VII polypeptides
CA2551510C (en) * 2003-12-23 2013-07-30 Pharmacia Corporation Stable growth hormone liquid formulation
WO2011147762A2 (en) * 2010-05-25 2011-12-01 Bayer Pharma Aktiengesellschaft Stabilized radiopharmaceutical composition
US9506867B2 (en) 2012-12-11 2016-11-29 Biogen Ma Inc. Spectroscopic analysis of nutrient materials for use in a cell culture process
EP2972238B1 (en) 2013-03-15 2023-04-26 Biogen MA Inc. Use of raman spectroscopy to monitor culture medium
US10563163B2 (en) 2014-07-02 2020-02-18 Biogen Ma Inc. Cross-scale modeling of bioreactor cultures using Raman spectroscopy
US20170276659A1 (en) * 2014-09-05 2017-09-28 Biogen Ma Inc. Systems and methods for assessing therapeutic proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations

Also Published As

Publication number Publication date
WO1997014430A1 (en) 1997-04-24
SE9503679D0 (en) 1995-10-20

Similar Documents

Publication Publication Date Title
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU4597596A (en) Prevention of protein aggregation
AU5801296A (en) Crosslinkable polypeptide compositions
AU3439195A (en) Cosmetic compositions
AU1152695A (en) Cosmetic compositions
AU4484997A (en) Compositions containing cobalamin and amino acids
AU7612494A (en) Cosmetic composition
AU6523194A (en) Compositions including heme-containing proteins and methods relating thereto
AU4851397A (en) Compositions for the preparation of leather
AU7068896A (en) Protein composition derived from sesame seed and use thereof
AU2514592A (en) Methods and compositions for modulating g protein action
AU7473294A (en) Stabilization of aerosolized proteins
AU2741197A (en) Natural antioxidant composition
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU1678995A (en) Synergistic antifungal protein and compositions containing same
AU7352096A (en) Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers
AU5716696A (en) Decorin binding protein compositions and methods of use
AU1159897A (en) Analogs of peptide yy and uses thereof
AU6345998A (en) Self-aggregating protein compositions and use as sealants
AU3461095A (en) Compositions and methods for delivery of polypeptides
AU1751892A (en) Novel peptide compositions and uses therefor
AU3217595A (en) Stabilized compositions containing hemoglobin
AU2507895A (en) Protein guarantor composition and its application
AU2467395A (en) Novel ophthalmologic uses of protein c
AU4905497A (en) Antimicrobial peptide analogs of gramicidin s and compositions comprising them